CIK 0001740279 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
IN8BIO, INC.
Sign in to watch- Ticker
- INAB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 825462585
- Phone
- (646) 600-6438
- Business address
- EMPIRE STATE BUILDING, 350 5TH AVENUE, SUITE 5330, NEW YORK, NY, 10118
- Former names
- Incysus Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 68 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-04 | Goswami Trishna Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2024-06-12 | Whitfill Travis Director | Grant or award · Stock Option (right to buy) | +33,650 | 33,650 | ||
| 2024-06-12 | Greenwood Luba Director | Grant or award · Stock Option (right to buy) | +33,650 | 33,650 | ||
| 2024-06-12 | Graff Jeremy R. Director | Grant or award · Stock Option (right to buy) | +33,650 | 33,650 | ||
| 2024-06-12 | FAIRBAIRN EMILY Director | Grant or award · Stock Option (right to buy) | +33,650 | 33,650 | ||
| 2024-06-12 | Epperly Corinne Director | Grant or award · Stock Option (right to buy) | +33,650 | 33,650 | ||
| 2024-06-12 | Brandt Peter C. Director | Grant or award · Stock Option (right to buy) | +33,650 | 33,650 | ||
| 2024-06-12 | Roemer Alan S. Director | Grant or award · Stock Option (right to buy) | +33,650 | 33,650 | ||
| 2024-02-07 | Epperly Corinne Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2024-02-07 | Ho William Tai-Wei PRESIDENT AND CEO | Grant or award · Employee Stock Option (right to buy) | +502,000 | 502,000 | ||
| 2024-02-07 | Goswami Trishna CHIEF MEDICAL OFFICER | Grant or award · Employee Stock Option (right to buy) | +176,000 | 176,000 | ||
| 2024-02-07 | Rochlin Kate CHIEF OPERATING OFFICER | Grant or award · Employee Stock Option (right to buy) | +186,000 | 186,000 | ||
| 2024-02-07 | Lamb Lawrence EVP AND CSO | Grant or award · Employee Stock Option (right to buy) | +169,000 | 169,000 | ||
| 2024-02-07 | McCall Patrick CHIEF FINANCIAL OFFICER | Grant or award · Employee Stock Option (right to buy) | +189,000 | 189,000 | ||
| 2023-12-13 | Graff Jeremy R. Director | Grant or award | +2,049 | 4,549 | ||
| 2023-12-13 | Graff Jeremy R. Director | Grant or award · Series A Warrants (right to buy) | +2,049 | 2,049 | ||
| 2023-12-13 | Graff Jeremy R. Director | Grant or award · Series B Warrants (right to buy) | +2,049 | 2,049 | ||
| 2023-12-13 | Epperly Corinne Director | Grant or award | +81,967 | 81,967 | ||
| 2023-12-13 | Epperly Corinne Director | Grant or award · Series A Warrants (right to buy) | +81,967 | 81,967 | ||
| 2023-12-13 | Epperly Corinne Director | Grant or award · Series B Warrants (right to buy) | +81,967 | 81,967 |
Page 7 of 9 · 179 trades